BSE filing, NSE: GKB. Summary written from the filing by ALFA Finder's alert engine.
GKB Ophthalmics Ltd: key numbers
- Share price
- ₹60.10
- Market cap
- ₹30.29 Cr
- Revenue (annual)
- ₹149.1 Cr
- Net profit (annual)
- ₹1.22 Cr
- P/E (TTM)
- 9.3×Sector 52.0×
- Promoter holding
- 51.15%+0.00% QoQ
- FII holding
- 1.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GKB Ophthalmics Ltd
All →GKB Ophthalmics Annual General Meeting
GKB Ophthalmics filed minutes of its 44th AGM held on 25 August 2026. It approved financial statements and re-appointed directors, declaring no dividend due to operating losses.
GKB Ophthalmics Annual General Meeting
GKB Ophthalmics Ltd held its 44th Annual General Meeting on August 25, 2026. Key resolutions included financial statement adoption and re-appointment of senior directors.
GKB Ophthalmics Q1 FY27 Results: Turns Profitable, Net Profit ₹1.8 Cr
GKB Ophthalmics Ltd reported revenue from operations of ₹33 Cr (+2.2% YoY) and net profit of ₹1.8 Cr for Q1 FY27.
- Key figure
- Net profit ₹1.8 Cr
GKB Ophthalmics Other Announcement
GKB Ophthalmics has provided shareholders with a web-link to access the Annual Report for F.Y. 2025-26, fulfilling Regulation 36(1)(b) disclosure requirements.
GKB Ophthalmics Annual General Meeting
GKB Ophthalmics Ltd has announced its 44th Annual General Meeting for August 25, 2026. Consequently, the Register of Members will be closed from August 19 to August 25.
GKB Ophthalmics Annual Report
GKB Ophthalmics Ltd. submitted its 44th Annual Report and AGM notice for the financial year 2025-26. The meeting is scheduled for August 25, 2026, at its registered office.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.